Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Mar 19 2026

Mar 19, 2026 at 8:37 AM EDT · Issued by Glenmark Pharmaceuticals Limited

Filed with NSE · Mar 19, 2026 at 8:37 AM EDT · 3 pages · English

On 6ix: 6ix.com/news/press-release-mar-19-2026-4

Release

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 19, 2026, titled "Glenmark Pharmaceuticals Inc., USA launches Authorized Generic to Milnacipran Hydrochloride Tablets, 12.5 mg, 25 mg, 50 mg, and 100 mg".

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Press Release Mar 16 2026Mar 16
Press Release Mar 04 2026Mar 4
Press Release Feb 27 2026Feb 27
Q3FY 2025-26Feb 4
Press Release Jan 30 2026Jan 30

Later from Glenmark Pharmaceuticals

Glenmark Pharmaceuticals Limited Press Release Mar 21 2026Mar 20
Glenmark Pharmaceuticals Announces Strategic Shift to Direct Commercialization and Distribution of RYALTRIS® in the U.S., Significantly Expanding Its Innovative PortfolioApr 1
Press Release Apr 01 2026Apr 1
Glenmark Pharmaceuticals Limited Press Release Apr 09 2026Apr 8
Press Release May 18 2026May 17

All Glenmark Pharmaceuticals news releases

Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.

Follow Glenmark Pharmaceuticals